{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T05:11:21Z","timestamp":1788930681902,"version":"build-2803163510"},"reference-count":34,"publisher":"Ubiquity Press, Ltd.","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,11,3]]},"DOI":"10.5334\/gh.850","type":"journal-article","created":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T11:03:51Z","timestamp":1604401431000},"source":"Crossref","is-referenced-by-count":17,"title":["Lipoprotein(a) and High Sensitivity C-Reactive Protein among Patients with HIV in Ghana: The Study on Cardiovascular Risk Profile of HIV-Infected Patients on HAART (SCRIPT)"],"prefix":"10.5334","volume":"15","author":[{"given":"Lambert Tetteh","family":"Appiah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred Stephen","family":"Sarfo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel Blay","family":"Nguah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark D.","family":"Huffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan K.","family":"Stiles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Feinstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3285","reference":[{"issue":"5","key":"key20201103060348_B1","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1001\/jamacardio.2018.0385","article-title":"The Burden of Cardiovascular Diseases Among US States, 1990\u20132016","volume":"3","author":"Global Burden of Cardiovascular Diseases Collaboration","year":"2018","journal-title":"JAMA Cardiol"},{"issue":"1","key":"key20201103060348_B2","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/QCO.0b013e328320a849","article-title":"Cardiovascular disease and HIV infection: host, virus, or drugs?","volume":"22","year":"2009","journal-title":"Curr Opin Infect Dis"},{"issue":"1","key":"key20201103060348_B3","first-page":"27","article-title":"Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study","volume":"43","year":"2006","journal-title":"J Acquir Immune Defic Syndr 1999"},{"issue":"11","key":"key20201103060348_B4","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.5603\/KP.2013.0301","article-title":"Cardiovascular diseases associated with HIV infection and their management","volume":"71","year":"2013","journal-title":"Kardiol Pol"},{"key":"key20201103060348_B5","article-title":"Cardiovascular risk factors among Ghanaian patients with HIV: A cross-sectional study","year":"2019","journal-title":"Clin Cardiol"},{"key":"key20201103060348_B6","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jns.2018.12.026","article-title":"Burden of subclinical carotid atherosclerosis and vascular risk factors among people living with HIV in Ghana","volume":"397","year":"2019","journal-title":"J Neurol Sci"},{"issue":"10","key":"key20201103060348_B7","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/clc.22753","article-title":"Current trends in admissions and outcomes of cardiac diseases in Ghana","volume":"40","year":"2017","journal-title":"Clin Cardiol"},{"issue":"3","key":"key20201103060348_B8","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ihj.2019.04.007","article-title":"Lipoprotein(a): An underrecognized genetic risk factor for malignant coronary artery disease in young Indians","volume":"71","year":"2019","journal-title":"Indian Heart J"},{"issue":"2","key":"key20201103060348_B9","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1161\/CIRCULATIONAHA.111.045120","article-title":"Associations Between Lipoprotein(a) Levels and Cardiovascular Outcomes in African Americans and Caucasians: The Atherosclerosis Risk in Communities (ARIC) Study","volume":"125","year":"2012","journal-title":"Circulation"},{"issue":"6","key":"key20201103060348_B10","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/CIRCULATIONAHA.113.004406","article-title":"Lipoprotein(a) Concentrations, Rosuvastatin Therapy, and Residual Vascular Risk: An Analysis from the JUPITER Trial","volume":"129","year":"2014","journal-title":"Circulation"},{"issue":"4","key":"key20201103060348_B11","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1161\/ATVBAHA.114.304785","article-title":"Race is a key variable in assigning lipoprotein(a) cutoff values for coronary heart disease risk assessment: The Multi-Ethnic Study of Atherosclerosis","volume":"35","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"14","key":"key20201103060348_B12","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1056\/NEJMoa032804","article-title":"C-Reactive Protein and Other Circulating Markers of Inflammation in the Prediction of Coronary Heart Disease","volume":"350","year":"2004","journal-title":"N Engl J Med"},{"issue":"1","key":"key20201103060348_B13","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1001\/archinte.166.1.64","article-title":"C-Reactive Protein Is a Marker for Human Immunodeficiency Virus Disease Progression","volume":"166","year":"2006","journal-title":"Arch Intern Med"},{"issue":"1","key":"key20201103060348_B14","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.atherosclerosis.2006.09.013","article-title":"The role of C-reactive protein as a marker for cardiovascular risk associated with antiretroviral therapy in HIV-infected patients","volume":"195","year":"2007","journal-title":"Atherosclerosis"},{"key":"key20201103060348_B15","unstructured":"World Health Organization. Waist circumference and waist-hip ratio: Report of a WHO expert consultation, Geneva, 8\u201311 December 2008 [Internet]. World Health Organization; 2011 [cited 2020 May 19]. https:\/\/apps.who.int\/iris\/handle\/10665\/44583 (assessed 19 May 2020)."},{"issue":"19","key":"key20201103060348_B16","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report","volume":"289","year":"2003","journal-title":"JAMA"},{"issue":"11","key":"key20201103060348_B17","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.jacc.2016.11.008","article-title":"2016 AHA\/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"69","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"key20201103060348_B18","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jacc.2017.11.014","article-title":"NHLBI Working Group Recommendations to Reduce Lipoprotein(a)-Mediated Risk of Cardiovascular Disease and Aortic Stenosis","volume":"71","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"25","key":"key20201103060348_B19","first-page":"e572","article-title":"CDC\/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: Laboratory tests available to assess inflammation \u2013 Performance and standardization: A background paper","volume":"110","author":"CDC AHA","year":"2004","journal-title":"Circulation"},{"issue":"23","key":"key20201103060348_B20","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1093\/eurheartj\/ehq386","article-title":"Lipoprotein(a) as a cardiovascular risk factor: current status","volume":"31","year":"2010","journal-title":"Eur Heart J"},{"issue":"25","key":"key20201103060348_B21","first-page":"e1082","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"139","year":"2019","journal-title":"Circulation"},{"issue":"20","key":"key20201103060348_B22","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1093\/eurheartj\/ehx233","article-title":"Lipoprotein(a)","volume":"38","year":"2017","journal-title":"Eur Heart J"},{"issue":"6","key":"key20201103060348_B23","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1258\/0956462054094006","article-title":"Clinical value of C-reactive protein measurements in HIV-positive patients","volume":"16","year":"2005","journal-title":"Int J STD AIDS"},{"issue":"1","key":"key20201103060348_B24","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0006-291X(88)81056-8","article-title":"The effect of interleukin-1, interleukin-6 and its interrelationship on the synthesis of serum amyloid A and C-reactive protein in primary cultures of adult human hepatocytes","volume":"155","year":"1988","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"key20201103060348_B25","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/S1047-2797(03)00053-X","article-title":"Relationship of total and abdominal adiposity with CRP and IL-6 in women","volume":"13","year":"2003","journal-title":"Ann Epidemiol"},{"issue":"4","key":"key20201103060348_B26","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1183\/09031936.05.00067604","article-title":"Procalcitonin and C-reactive protein levels in HIV-positive subjects with tuberculosis and pneumonia","volume":"25","year":"2005","journal-title":"Eur Respir J"},{"issue":"9","key":"key20201103060348_B27","article-title":"Inflammation, coagulation and cardiovascular disease in HIV-infected individuals","volume":"7","year":"2012","journal-title":"PloS One"},{"issue":"2","key":"key20201103060348_B28","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0735-1097(00)01126-8","article-title":"Lipoprotein(a) further increases the risk of coronary events in men with high global cardiovascular risk","volume":"37","year":"2001","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"key20201103060348_B29","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1468-1293.2008.00574.x","article-title":"Lipoprotein(a) in patients initiating antiretroviral therapy","volume":"9","year":"2008","journal-title":"HIV Med"},{"issue":"2","key":"key20201103060348_B30","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1161\/ATVBAHA.112.300125","article-title":"HIV Disease Activity as a Modulator of Lipoprotein(a) and Allele-Specific Apolipoprotein(a) Levels","volume":"33","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"key20201103060348_B31","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1172\/JCI115855","article-title":"Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations","volume":"90","year":"1992","journal-title":"J Clin Invest"},{"issue":"8","key":"key20201103060348_B32","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1097\/00002030-200305230-00010","article-title":"Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study","volume":"17","year":"2003","journal-title":"AIDS Lond Engl"},{"issue":"1","key":"key20201103060348_B33","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1056\/NEJMra041811","article-title":"Cardiovascular Risk and Body-Fat Abnormalities in HIV-Infected Adults","volume":"352","year":"2005","journal-title":"N Engl J Med"},{"issue":"2","key":"key20201103060348_B34","first-page":"e98","article-title":"Characteristics, Prevention, and Management of Cardiovascular Disease in People Living With HIV: A Scientific Statement from the American Heart Association","volume":"140","year":"2019","journal-title":"Circulation"}],"container-title":["Global Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/doi.org\/10.5334\/gh.850","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,26]],"date-time":"2022-11-26T09:58:12Z","timestamp":1669456692000},"score":1,"resource":{"primary":{"URL":"https:\/\/globalheartjournal.com\/articles\/10.5334\/gh.850\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,11,3]]}},"alternative-id":["10.5334\/gh.850"],"URL":"https:\/\/doi.org\/10.5334\/gh.850","relation":{},"ISSN":["2211-8179"],"issn-type":[{"value":"2211-8179","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]},"article-number":"74"}}